Department of Orthopaedics and Traumatology, Faculty of Medicine, Eskişehir Osmangazi University, 26480, Eskisehir, Turkey.
Arch Orthop Trauma Surg. 2012 Sep;132(9):1281-5. doi: 10.1007/s00402-012-1554-z. Epub 2012 May 27.
The aim of this case series was to assess the effect of two common causes of inherited thrombophilia, factor V Leiden (FVL) and prothrombin mutation (PTM) on the development of osteonecrosis of the femoral head (ONFH) following the treatment of developmental dysplasia of the hip (DDH).
FVL and PTM analysis of 58 patients (45 females and 13 males; mean age 12.2 years) with ONFH due to DDH treatment was done.
Rate of inherited thrombophilia (FVL plus PTM) was 15.5 %. Inherited thrombophilia was nearly four times higher in male patients than in female patients and this difference was mainly due to FVL (P < 0.05). This finding was against the common belief that, coagulation abnormalities were equally distributed across the sexes in normal population. Rates of overall inherited thrombophilia, FVL and PTM were not correlated with the type of ONFH (P > 0.05).
Hereditary thrombophilia, especially FVL, may be one of the causative factors for the development of ONFH following DDH treatment in male patients. Further prospective, controlled studies are needed to undoubtedly enlighten this issue.
本病例系列旨在评估两种常见遗传性血栓形成倾向(因子 V Leiden [FVL] 和凝血酶原突变 [PTM])对发育性髋关节发育不良(DDH)治疗后股骨头坏死(ONFH)发展的影响。
对 58 例(45 名女性和 13 名男性;平均年龄 12.2 岁)因 DDH 治疗而发生 ONFH 的患者进行了 FVL 和 PTM 分析。
遗传性血栓形成倾向(FVL 加 PTM)的发生率为 15.5%。男性患者中遗传性血栓形成倾向的发生率几乎是女性患者的四倍,这种差异主要归因于 FVL(P<0.05)。这一发现与普遍认为的在正常人群中凝血异常在性别之间均匀分布的观点相悖。总体遗传性血栓形成倾向、FVL 和 PTM 的发生率与 ONFH 的类型无关(P>0.05)。
遗传性血栓形成倾向,尤其是 FVL,可能是 DDH 治疗后男性患者发生 ONFH 的一个原因。需要进一步进行前瞻性、对照研究来明确这一问题。